The announcement by NYU Langone’s Board of Trustees was praised by Kenneth Langone, board chair and co-chair of the search ...

The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...

Kimmelman, MD, PhD, as its next Chief Executive Officer and Dean of NYU Grossman School of Medicine ... of the Laura and Isaac Perlmutter Cancer Center at NYU Langone since 2023 and has been ...

NYU Langone Health tapped Alec Kimmelman to succeed Robert Grossman as its next CEO and dean of the NYU Grossman School of ...

The appointment comes almost a year after Grossman and Kenneth Langone, chair of NYU’s board of trustees, announced their ...

New York City based NYU Langone Health has selected Alec Kimmelman, MD, PhD, as the next CEO and dean of NYU Grossman School of Medicine, effective Sept. 1. Dr. Kimmelman, a researcher and radiation ...

and Virginia Connolly Mitty Chair; Director, Division of Medical Ethics, Department of Population Health, NYU Robert I. Grossman School of Medicine ... Fox Chase Cancer Center; Abeona; Genae ...

A study led by scientists at NYU Langone Health ... The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial ...

Dr. Jeffrey Flier is an endocrinologist and a professor at Harvard Medical School, where he was the dean from 2007 to 2016.